1-3 of 3
Chia-Min Chu
Close
Sort by
Journal Articles

Secondary Myelodysplastic Syndrome/Acute Myeloblastic Leukemia During Lenalidomide-Based Regimens in Relapsed and/or Refractory Multiple Myeloma Patients: Single Center Experience

Rouslan Kotchetkov, MD, Esther Masih-Khan, PhD, Chia-Min Chu, Young Trieu, Saima Dean, Manjula Maganti, Christine I. Chen, MD, Vishal Kukreti, MD, Suzanne Trudel, MD, MSC, FRCPC, Donna E. Reece, MD, FRCPC
Journal: Blood
Blood (2012) 120 (21): 1867.
https://doi.org/10.1182/blood.V120.21.1867.1867
Published: 2012
Journal Articles

Central Nervous System (CNS) Involvement with Multiple Myeloma (MM) – Longterm Survival Can Be Achieved with Radiation, Intrathecal (IT) Chemotherapy, and Immunomodulatory Agents (IMiDs),

Christine Chen, MD, MEd, FRCPC, Ahmed M. Rabea, MD, Esther Masih-Khan, PhD, Chia-Min Chu, Vishal Kukreti, MD, FRCPC, Suzanne Trudel, MD, MSC, FRCPC, Rodger E. Tiedemann, MD PhD FRACP FRCPA, Donna E. Reece, MD, FRCPC
Journal: Blood
Blood (2011) 118 (21): 3983.
https://doi.org/10.1182/blood.V118.21.3983.3983
Published: 2011
Journal Articles

Activity with Thalidomide-Based Therapy Following Lenalidomide Plus Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma.

Trieu Young, MSc, Chia-Min Chu, Wei Xu, PhD, Peter Anglin, MD, Suzanne Trudel, MD, Donna E. Reece, MD, Christine Chen, MD, Vishal Kukreti, MD, FRCPC
Journal: Blood
Blood (2009) 114 (22): 3855.
https://doi.org/10.1182/blood.V114.22.3855.3855
Published: 2009